About us

Principal Investigator, John K. Heussy, MD is a board-certified psychiatrist who has been practicing in the Greenwich Village area of Manhattan since 1996. After completing his undergraduate education at Harvard University, Dr. Heussy attended NYU School of Medicine.

He continued his clinical education at NYU and in 1996, completed his residency training at the NYU-Bellevue Department of Psychiatry .
Dr. Heussy has been an investigator in over 30 clinical trials and maintains an active private practice.

Sub-Investigator, Pauline McHugh, MD is a board-certified psychiatrist who has combined a private practice with academic psychiatry and clinical research since she completed her residency training at the NYU-Bellevue Department of Psychiatry in 1998. Dr. McHugh obtained her BA from The Johns Hopkins University and attended medical school at the Vermont University College of Medicine. Following her residency training, she completed a Clinical Scholar Fellowship at the Rockefeller University, where her research focused on the biology of Addictive Diseases. For the past 10 years she has conducted academic and clinical research in the area of Alzheimer’s Disease and other cognitive disorders. 

Lead Clinical Research Coordinator, Kari Elfar, BA studied psychology at New York University and has nearly 4 years experience in psychiatric clinical research. Ms.Elfar is IATA certified and excels in accurate rating scales, regulatory submission and organization, conduct of protocol procedures, and prompt correspondence with sponsors, monitors, Institutional Review Boards (IRB), and vendors.

As a psychiatrist and psychotherapist for over 15 years, I have come to appreciate the value of medication in treating patients suffering from mental illness. However, I have also become aware of the limitations of currently available medications. Moreover, during the past several years, like you, I have witnessed the increasing restrictions imposed by health insurance companies and the mounting financial stresses patients are confronting in order to obtain psychiatric medication. In 2005, in response to these observations, I began to participate as a Principal Investigator in clinical research in psychiatry. In 2009, I founded Village Clinical Research Inc., a research site dedicated to the safe and ethical conduct of Phase II-IV clinical trials, exploring new medications for psychiatric disorders. 

As a clinical investigator, I recognize that at the heart of clinical research is the immeasurable contribution of those who volunteer to participate in clinical trials.  It is therefore my commitment to protect the safety and well-being of those who enroll in our studies. While participation in a clinical trial is somewhat different from traditional treatment, such participation may offer access to medication which some patients might not otherwise have. Further, participating in a study allows patients the opportunity to make an meaningful contribution to the development of safer and more effective treatments for the illnesses from which they may suffer. – John K. Heussy, MD

about usshapeimage_9_link_0